Comparative evaluation of oral and intranasal priming with replication-competent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIVmac251
- 29 September 2007
- Vol. 25 (47) , 8021-8035
- https://doi.org/10.1016/j.vaccine.2007.09.017
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidatesExpert Review of Vaccines, 2006
- Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV developmentExpert Review of Vaccines, 2006
- Complete Protection of Neonatal Rhesus Macaques against Oral Exposure to Pathogenic Simian‐Human Immunodeficiency Virus by Human Anti‐HIV Monoclonal AntibodiesThe Journal of Infectious Diseases, 2004
- Progress in the development of an HIV vaccineEmerging Drugs, 2003
- Immunologic correlates of protection induced by vaccinationThe Pediatric Infectious Disease Journal, 2001
- Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infectionNature Medicine, 2000
- Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodiesNature Medicine, 2000
- Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected MacaquesThe Journal of Experimental Medicine, 1999
- Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + LymphocytesScience, 1999
- Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of ViremiaScience, 1997